Correlation Between C4 Therapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on C4 Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for C4 Therapeutics and Corvus Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CCCC and Corvus is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Corvus Pharmaceuticals
Given the investment horizon of 90 days C4 Therapeutics is expected to under-perform the Corvus Pharmaceuticals. In addition to that, C4 Therapeutics is 1.05 times more volatile than Corvus Pharmaceuticals. It trades about -0.25 of its total potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest 521.00 in Corvus Pharmaceuticals on December 27, 2024 and sell it today you would lose (184.00) from holding Corvus Pharmaceuticals or give up 35.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
C4 Therapeutics vs. Corvus Pharmaceuticals
Performance |
Timeline |
C4 Therapeutics |
Corvus Pharmaceuticals |
C4 Therapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with C4 Therapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite C4 Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |